We recently compiled a list of the 10 Buzzing AI Health Stocks. In this article, we are going to take a look at where Abbott ...

At its current valuation, DexCom stock is the opposite of a bargain. Even after its big drop over the summer, it would still be a risky stock to buy now. Those who are interested would probably do ...

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

ABT), which markets the FreeStyle Libre brand of CGM devices. The FreeStyle Libre is only responsible for about 15% of Abbott's total revenue, but its sales are rising fast. In the second quarter ...

In 2008 Abbott introduced a revolutionary new device, FreeStyle Navigator, designed to improve the lives of the world’s more than 500 million diabetes patients by offering continuous glucose ...

Ascensia Diabetes Care, a global diabetes care company, announces that it is launching the Eversense® 365 continuous glucose monitoring (CGM) system, the world's only One Year CGM, to people with ...

A “fully integrated, wearable” continuous glucose monitor (CGM) is set to transform diabetes care, researchers have said.

Medtronic found that dropping, bumping, or hits to the MiniMed device could result in a shortened battery life.

Doctors fear losing access to essential formulas for premature babies Plaintiffs argue companies failed to warn about NEC risk from cow's milk-based formula The closely watched trial in St. Louis ...

On September 26, the U.S. Court of Appeals for the Second Circuit issued a ruling in Abbott Laboratories v. H&H Wholesale ...